A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle
Abstract
Since its emergence in December 2019, COVID-19 has remained a global economic and health threat. Although RNA and DNA vector-based vaccines induced antibody response and immunological memory have proven highly effective against hospitalization and mortality, their long-term efficacy remains unknown against continuously evolving SARS-CoV-2 variants.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 23, 2022
- Source ID
- 10.1128/spectrum.02364-21
Entities
People
- Alaa Habieb
- Gururaj Shivange
- Jogender Tushir‐Singh
- Tanmoy Mondal
Organizations
- National Cancer Institute
- United States Department of Defense
- University of California
- University of Virginia